The Effect of 5-Hydroxytryptophan (5-HTP) on Satiety
NCT00328913 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2007-01-09
Summary
The aim of the study is to show evidence of the efficacy of 5-HTP to induce satiety and to reduce food intake (confirmatory study).
The primary objective of the present study is to determine:
* the effectiveness of a 5-HTP preparation on satiety markers (before intake of a meal and during the day)
The secondary objectives of the present study are to determine the effectiveness of a 5-HTP preparation on:
* food consumption (amount and composition) during a free meal (dinner);
* wellness after one week supplementation;
* the intermeal interval;
* body weight and waist-hip ratio (WHR).
Conditions
Interventions
- DRUG
-
5-hydroxytryptophan (food supplement)
Sponsors & Collaborators
-
Laboratoire Oenobiol
collaborator UNKNOWN -
TNO
lead OTHER
Principal Investigators
-
Wilrike Pasman, PhD · TNO
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-03-31
- Completion
- 2006-07-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity
NCT00339014 ·Status: COMPLETED ·Phase: PHASE2
-
Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.
NCT00759993 ·Status: TERMINATED ·Phase: PHASE2
-
Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM
NCT05405244 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Modafinil to Counteract the Adverse Metabolic Consequences of Sleep Restriction
NCT00895570 ·Status: COMPLETED ·Phase: NA
-
Brain Dopamine Function in Human Obesity
NCT03648892 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Do Antidepressants Induce Metabolic Syndromes METADAP Study
NCT00526383 ·Status: COMPLETED ·Phase: NA
-
Bromocriptine and Insulin Sensitivity
NCT02428946 ·Status: COMPLETED ·Phase: NA
-
Brain, Obesity, Dopamine and You Study
NCT01094756 ·Status: COMPLETED ·Phase: NA
-
Impact of Hesperetin in Combination With Sucrose on Energy Metabolism
NCT05705596 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Herbal Products on Metabolism and Hunger
NCT00198952 ·Status: COMPLETED ·Phase: NA
-
Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects
NCT01103726 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body
NCT00800280 ·Status: TERMINATED ·Phase: PHASE1
-
Determining Metabolic Effects of Valproate and Antipsychotic Therapy
NCT00167934 ·Status: COMPLETED ·Phase: NA
-
Green Tea Extract for Obesity of Psychiatric Patients
NCT03548103 ·Status: COMPLETED ·Phase: NA
-
Alleviating the Metabolic Side Effects of Antipsychotic Medications
NCT01567124 ·Status: WITHDRAWN ·Phase: PHASE4
-
Glucose and Lipid Metabolism on Antipsychotic Medication
NCT00515723 ·Status: COMPLETED ·Phase: NA
-
Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
NCT00617240 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Drug Liking In Peri-procedural Clinical Settings
NCT07015528 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
A New Supplement for the "Metabolic Syndrome"
NCT03813914 ·Status: COMPLETED ·Phase: NA
-
Berberine Treat Metabolic Syndrome in Schizophrenia
NCT03251716 ·Status: COMPLETED ·Phase: NA
-
The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals
NCT02536846 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of LDX on Cognitive Processes and Appetite
NCT04181957 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
NCT01071044 ·Status: COMPLETED ·Phase: PHASE4
-
The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity
NCT01384279 ·Status: COMPLETED ·Phase: NA
-
Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
NCT00552500 ·Status: COMPLETED ·Phase: NA